©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 110183
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.110183
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.110183
Table 2 Basic characteristics of subjects, mean ± SD/n (total)
| Parameters | Control | T2DM-nonIR | T2DM-IR | P value |
| Basic characteristics | ||||
| Age (years) | 55.31 ± 9.55 | 55.40 ± 7.97 | 61.67 ± 8.93 | 0.031 |
| Sex | F: 27, M: 11 | F: 23, M: 17 | F: 8, M: 10 | 0.145 |
| Height (m) | 1.64 ± 0.05 | 1.62 ± 0.08 | 1.61 ± 0.08 | 0.151 |
| Weight (kg) | 64.65 ± 9.10 | 62.57 ± 9.07 | 64.36 ± 9.72 | 0.742 |
| BMI (kg/m2) | 23.83 ± 2.97 | 23.76 ± 2.55 | 24.91 ± 2.82 | 0.395 |
| Waist circumstance (cm) | 78.63 ± 24.07 | 87.57 ± 10.59 | 93.67 ± 7.45 | 0.021 |
| Diabetes history | ||||
| Disease course (years) | / | 6.93 ± 6.68 | 11.94 ± 8.92 | 0.000 |
| Bad control of diabetes | 0 (39) | 35 (40) | 15 (18) | 0.000 |
| Blood glucose (mmol/L) | 4.88 ± 0.20 | 13.10 ± 7.47 | 10.93 ± 5.47 | 0.011 |
| HbA1c (%) | / | 8.59 ± 2.77 | 8.20 ± 1.60 | 0.911 |
| HOMA-IR | / | 0.66 ± 0.37 | 4.48 ± 3.02 | 0.000 |
| Insulin (μIU/mL) | / | 19.38 ± 12.39 | 44.55 ± 38.30 | 0.087 |
| C-peptide (ng/mL) | / | 3.89 ± 2.32 | 4.09 ± 3.02 | 0.874 |
| Cardiovascular history and dyslipidemia | ||||
| Cardiovascular disease | 0 | 1 | 2 | 0.088 |
| Hypertension | 11 (39) | 15 (40) | 7 (18) | 0.609 |
| Total cholesterol | / | 4.20 ± 0.97 | 3.95 ± 1.11 | 0.495 |
| Triglyceride | / | 1.89 ± 1.31 | 1.68 ± 1.13 | 0.296 |
| HDL-C | / | 1.09 ± 0.23 | 1.20 ± 0.45 | 0.545 |
| Lifestyle | ||||
| Smoking history | 1 (39) | 6 (40) | 3 (18) | 0.081 |
| Alcohol history | 1 (39) | 7 (40) | 3 (18) | 0.050 |
- Citation: Hou BW, Ran Z, Li YT, Zhang J, Chu YQ, Gharaibeh NM, Li XM. Magnetic resonance imaging derived biomarkers for the diagnosis of type 2 diabetes with insulin resistance: A pilot study. World J Diabetes 2025; 16(9): 110183
- URL: https://www.wjgnet.com/1948-9358/full/v16/i9/110183.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i9.110183